Company / Return on Equity (ROE)
VYCOR MEDICAL INC Return on Equity (ROE) History
FY2017-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-18.2%
FY2021
5-year range
-18.2% / -18.2%
FY2017-FY2021
Trend
-
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
VYCOR MEDICAL INC reports negative total equity of -18.2% in FY2021. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-18.2% in FY2021.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Altman Z-Score -35.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -18.2% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -1813.6% | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 29, 2026